Skip to content

MXCT - MAXCYTE, INC. - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchM

MaxCyte Inc

MXCT · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

M

MXCTMaxCyte Inc

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 21

52-wk high: $1.87
52-wk low: $0.64
Prev close: $1.27
Mkt cap: $143.5M
Beta: 1.49
P/S: 4.6x

Smart money

8 funds hold a position.

Real smart money

Funds holding this stock

8 holders

Combined position$14.6M

JS
Jim Simons
Q2 2026 13F
$2.4M
position
AQ
AQR
Q2 2026 13F

Earnings

Reported Aug 12, 2026

Earnings came in 33.3% above what analysts expected.

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is not yet profitable.

Net margin: -114.8%
Market cap: $143M

Valuation

P/S4.62
P/B0.83

Quality

Operating margin-140.7%
ROE

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: MXCT
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: MEDICAL DEVICES
Market cap: $143.46M
Beta: 1.49

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

P/B

0.8x

Profit margin

-114.8%

Op margin

-140.7%

ROE

-20.4%

$2.3M

position

TS

Two Sigma

Q2 2026 13F

$1.8M

position

5 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 5 holders

Coverage gaps for MXCT

No recent insider trade
No recent Congress trade
No recent market-voice mention

Earnings per share

-$0.08+33.3%

-$0.12 expected

Next report

What the street expects next

EPS expected

-$0.08

-$0.09 to -$0.08

Revenue expected

$6.9M

5 analysts

Last 30 days

0up1down

Analysts cutting estimates

Estimate drift

0.01

Change in 30 days

-20.4%

ROA-10.6%

Growth

Beta1.49